OTCMKTS:CMPD CompuMed - CMPD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CompuMed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.21 +0.01 (+0.31%) (As of 02/7/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.10▼$3.2650-Day Range$2.68▼$3.4352-Week Range$2.60▼$5.00Volume1,857 shsAverage Volume1,903 shsMarket Capitalization$3.82 millionP/E Ratio10.03Dividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsHeadlinesShort Interest About CompuMed (OTCMKTS:CMPD) StockCompuMed, Inc. engages in the provision of enterprise telemedicine solutions. It specializes in telecardiology, teleradiology, osteoporosis and mobile diagnostics. The company was founded by Robert Stuckelman in 1973 and is headquartered in Los Angeles, CA.Read More Receive CMPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CompuMed and its competitors with MarketBeat's FREE daily newsletter. Email Address CMPD Stock News HeadlinesJanuary 23, 2023 | msn.comCMPD investigating DWI crash involving off-duty officer, separate crash involving police cruisersJanuary 17, 2023 | msn.com1 dead after shooting into cars, apartments, CMPD saysFebruary 7, 2023 | Wall Street Watch Dogs (Ad)The #1 Energy Stock to BuyThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…January 12, 2023 | msn.comCMPD: Woman waving knife struck and killed by car in CharlotteDecember 27, 2022 | benzinga.comCompumed, Inc. Announces Fiscal 2022 Annual and Fourth Quarter ResultsOctober 6, 2022 | msn.comShots fired into home with more than a dozen people inside: CMPDSeptember 14, 2022 | finance.yahoo.comCompuMed, Inc. (CMPD)August 12, 2022 | finance.yahoo.comCompuMed, Inc. Announces Fiscal 2022 Third Quarter ResultsFebruary 7, 2023 | Wall Street Watch Dogs (Ad)The #1 Energy Stock to BuyThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…May 23, 2022 | finanznachrichten.deCompuMed, Inc.: CompuMed Announces Approval of Reverse Stock SplitMay 23, 2022 | seekingalpha.comCompuMed announces a 1-for-25 reverse stock splitMay 23, 2022 | finance.yahoo.comCompuMed Announces Approval of Reverse Stock SplitMay 16, 2022 | seekingalpha.comCompuMed reports FQ2 resultsMay 15, 2022 | benzinga.comFISCAL 2022 SECOND QUARTER:May 13, 2022 | finanznachrichten.deCompuMed, Inc.: Compumed, Inc. Announces Fiscal 2022 Second Quarter ResultsMay 13, 2022 | finance.yahoo.comCompumed, Inc. Announces Fiscal 2022 Second Quarter ResultsApril 20, 2022 | finance.yahoo.comCompuMed Press Release re Reverse Stock SplitMarch 24, 2022 | finanznachrichten.deCompuMed, Inc.: CompuMed Inc. Announces Results of Shareholder VotingMarch 22, 2022 | finance.yahoo.comCompuMed Inc. Announces Results of Shareholder VotingFebruary 14, 2022 | finance.yahoo.comCompuMed, Inc. Announces Fiscal 2022 First Quarter ResultsJanuary 25, 2022 | nasdaq.comCMPD Price/Earnings & PEG RatiosDecember 16, 2021 | finance.yahoo.comCOMPUMED, INC. ANNOUNCES FISCAL 2021 ANNUAL AND FOURTH QUARTER RESULTSSeptember 13, 2021 | finance.yahoo.comCompuMed, Inc. Announces Fiscal 2021 Third Quarter ResultsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CMPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CompuMed and its competitors with MarketBeat's FREE daily newsletter. Email Address CMPD Company Calendar Today2/07/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Data processing & preparation Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CMPD CUSIPN/A CIKN/A Webwww.compumed.net Phone(310) 258-5000Fax310-645-5880Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.32 Trailing P/E Ratio10.03 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.07 million Net Margins12.07% Pretax Margin12.20% Return on Equity21.49% Return on Assets14.24% Debt Debt-to-Equity Ratio0.10 Current Ratio2.34 Quick Ratio2.22 Sales & Book Value Annual Sales$6.32 million Price / Sales0.60 Cash Flow$0.93 per share Price / Cash Flow3.44 Book Value$2.06 per share Price / Book1.56Miscellaneous Outstanding Shares1,190,000Free Float924,000Market Cap$3.82 million OptionableNot Optionable Beta0.95 Key ExecutivesLee D. KeddiePresident, Chief Executive Officer & DirectorLaura N. CarrollChief Financial Officer & SecretaryKey CompetitorsAkernaNASDAQ:KERNMGT Capital InvestmentsOTCMKTS:MGTIDermata TherapeuticsNASDAQ:DRMABiondVax PharmaceuticalsNASDAQ:BVXVCannaPharmaRXOTCMKTS:CPMDView All Competitors CMPD Stock - Frequently Asked Questions How have CMPD shares performed in 2023? CompuMed's stock was trading at $3.10 at the beginning of the year. Since then, CMPD stock has increased by 3.5% and is now trading at $3.21. View the best growth stocks for 2023 here. Are investors shorting CompuMed? CompuMed saw a increase in short interest in December. As of December 30th, there was short interest totaling 5,300 shares, an increase of 6.0% from the December 15th total of 5,000 shares. Based on an average trading volume of 4,200 shares, the short-interest ratio is presently 1.3 days. View CompuMed's Short Interest. What is CompuMed's stock symbol? CompuMed trades on the OTCMKTS under the ticker symbol "CMPD." How do I buy shares of CompuMed? Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CompuMed's stock price today? One share of CMPD stock can currently be purchased for approximately $3.21. How much money does CompuMed make? CompuMed (OTCMKTS:CMPD) has a market capitalization of $3.82 million and generates $6.32 million in revenue each year. The company earns $1.07 million in net income (profit) each year or $0.32 on an earnings per share basis. How can I contact CompuMed? CompuMed's mailing address is 5777 West Century Blvd. Suite 360, Los Angeles CA, 90045. The official website for the company is www.compumed.net. The company can be reached via phone at (310) 258-5000, via email at investorrelations@compumedinc.com, or via fax at 310-645-5880. This page (OTCMKTS:CMPD) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.